» Articles » PMID: 12231489

Midthigh Muscle Cross-sectional Area is a Better Predictor of Mortality Than Body Mass Index in Patients with Chronic Obstructive Pulmonary Disease

Overview
Specialty Critical Care
Date 2002 Sep 17
PMID 12231489
Citations 257
Authors
Affiliations
Soon will be listed here.
Abstract

This study was undertaken to test the hypothesis that a reduction in midthigh muscle cross-sectional area obtained by CT scan (MTCSA(CT)) is a better predictor of mortality in chronic obstructive pulmonary disease (COPD) than low body mass index (BMI). We also wished to evaluate whether anthropometric measurements could be used to estimate MTCSA(CT). One hundred forty-two patients with COPD (age = 65 +/- 9 years, mean +/- SD, 26 F, BMI = 26 +/- 6 kg/m(2), FEV(1) = 42 +/- 16% predicted) were recruited from September 1995 to April 2000 with a mean follow-up of 41 +/- 18 months. The primary end-point was all-cause mortality during the study period. A Cox proportional hazards regression model was used to predict mortality using the following independent variables: age, sex, daily use of corticosteroid, FEV(1), DL(CO), BMI, thigh circumference, MTCSA(CT), peak exercise workrate, Pa(O2), and Pa(CO2). Only MTCSA(CT) and FEV(1) were found to be significant predictors of mortality (p = 0.0008 and p = 0.01, respectively). A second analysis was also performed with FEV(1) and MTCSA(CT) dichotomized. Patients were divided into four subgroups based on FEV(1) (< or >or= 50% predicted) and MTCSA(CT) (< or >or= 70 cm(2)). Compared with patients with an FEV(1) >or= 50% predicted and a MTCSA(CT) >or= 70 cm(2), those with an FEV(1) < 50% predicted and a MTCSA(CT) >or= 70 cm(2) had a mortality odds ratio of 3.37 (95% confidence interval, 0.41-28.00), whereas patients with an FEV(1) < 50% predicted and a MTCSA(CT) < 70 cm(2) had a mortality odds ratio of 13.16 (95% confidence interval, 1.74-99.20). MTCSA(CT) could not be estimated with sufficient accuracy from anthropometric measurements. In summary, we found in this cohort of patients with COPD that (1) MTCSA(CT) was a better predictor of mortality than BMI, and (2) MTCSA had a strong impact on mortality in patients with an FEV(1) < 50% predicted. These findings suggest that the assessment of body composition may be useful in the clinical evaluation of these patients.

Citing Articles

Muscle Mass Index Decline as a Predictor of Lung Function Reduction in the General Population.

Choi J, Rhee C, Kim S, Jo Y J Cachexia Sarcopenia Muscle. 2024; 16(1):e13663.

PMID: 39686869 PMC: 11693984. DOI: 10.1002/jcsm.13663.


The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.

Tenda E, Henrina J, Setiadharma A, Felix I, Yulianti M, Pitoyo C Eur Respir Rev. 2024; 33(174).

PMID: 39603663 PMC: 11600125. DOI: 10.1183/16000617.0261-2023.


Correlation Between Hyperlipidemia-Related Diseases and Thorax/Thigh Circumference Ratio Along with Body Condition Score in Dogs Focusing on Molecular Mechanism: A Pilot Study and Literature Review.

Choi K Life (Basel). 2024; 14(11).

PMID: 39598239 PMC: 11595692. DOI: 10.3390/life14111441.


A Pilot Study on Proteomic Predictors of Mortality in Stable COPD.

Enriquez-Rodriguez C, Casadevall C, Faner R, Pascual-Guardia S, Castro-Acosta A, Lopez-Campos J Cells. 2024; 13(16).

PMID: 39195241 PMC: 11352814. DOI: 10.3390/cells13161351.


Longitudinal change in ultrasound-derived rectus femoris cross-sectional area in COPD.

Jenkins T, Patel S, Edwards G, M Nolan C, Canavan J, Kon S ERJ Open Res. 2024; 10(4).

PMID: 39076527 PMC: 11284593. DOI: 10.1183/23120541.00123-2024.